Charles River Laboratories (CRL) EVP LaPlume reports bona fide gift of 257 shares
Rhea-AI Filing Summary
Charles River Laboratories International, Inc. executive Joseph W. LaPlume, EVP, Corp Strategy & Develop, reported a bona fide gift of 257 shares of common stock on 2026-08-10. The transaction was a disposition made at a reported per-share price of $0.00, leaving him with 31,041 shares of direct ownership afterward.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 257 shares
Net Sell
1 txn
Insider
LaPlume Joseph W
Role
EVP, Corp Strategy & Develop
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Gift | Common Stock | 257 | $0.00 | $0.00 |
Holdings After Transaction:
Common Stock — 31,041 shares (Direct)
Key Figures
Shares gifted: 257 shares
Per-share price reported: $0.00 per share
Shares owned after transaction: 31,041 shares
+2 more
5 metrics
Shares gifted
257 shares
Bona fide gift of common stock on 2026-08-10
Per-share price reported
$0.00 per share
Reported transaction price for the gifted shares
Shares owned after transaction
31,041 shares
Direct common stock holdings following the gift
Gift transactions count
1 transaction
Single bona fide gift reported in this Form 4
Gifted share total
257 shares
Total shares involved in gift transactions in this filing
Key Terms
bona fide gift, Form 4, direct ownership
3 terms
bona fide gift financial
"The transaction code G is described as a bona fide gift."
A bona fide gift is a genuine, voluntary transfer of money, property, or benefits from one party to another made without expectation of repayment, services, or hidden conditions. Investors care because such gifts can affect company disclosures, related‑party transaction rules, tax treatment, and perceived conflicts of interest; think of it like someone giving you a present with no strings attached — but on a corporate scale, auditors and regulators need to verify it really is unconditional.
Form 4 regulatory
"Insider transaction by an officer is reported on Form 4."
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
direct ownership financial
"Ownership type for the reported common stock is direct ownership."
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transaction did CRL executive Joseph W. LaPlume report?
Joseph W. LaPlume reported a bona fide gift of 257 shares of Charles River Laboratories common stock on 2026-08-10, classified as a disposition with a reported price of $0.00 per share.
What are Joseph W. LaPlume’s CRL holdings after the reported gift?
Following the reported bona fide gift of 257 shares, Joseph W. LaPlume’s direct ownership position in Charles River Laboratories common stock is listed as 31,041 shares in the Form 4 data.
Did Joseph W. LaPlume use a Rule 10b5-1 trading plan for this CRL transaction?
The Form 4 data indicates the Rule 10b5-1 checkbox is not affirmed (aff_10b5_one is false), so this reported bona fide gift of 257 shares was not disclosed as made under a Rule 10b5-1 plan.